Intercept Pharmaceuticals Inc.

07/07/2022 | Press release | Distributed by Public on 07/07/2022 05:36

Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)